Pharmacy Times September 17, 2024
In 2021, cancer diagnosis rates remained low after major disruptions during the first year of the COVID-19 pandemic.
A population-based cross-sectional study of cancer incidence trends in the United States found that the rates of cancer diagnosis improved in 2021 after major disruptions due to the COVID-19 pandemic but have continued to be lower than expected and increased the existing deficit of diagnosed cases, according to results published in the Journal of the American Medical Association.1
The disruptions in cancer cases since the coronavirus pandemic have been well-documented in previously published literature. In a previous study by the same research team, they found that all-sites cancer incidence in the US was significantly lower than expected in March through December 2020.2
...Today's Sponsors
Today's Sponsor